BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 23264732)

  • 1. Molecular chaperones protect against JNK- and Nmnat-regulated axon degeneration in Drosophila.
    Rallis A; Lu B; Ng J
    J Cell Sci; 2013 Feb; 126(Pt 3):838-49. PubMed ID: 23264732
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mislocalization of neuronal mitochondria reveals regulation of Wallerian degeneration and NMNAT/WLD(S)-mediated axon protection independent of axonal mitochondria.
    Kitay BM; McCormack R; Wang Y; Tsoulfas P; Zhai RG
    Hum Mol Genet; 2013 Apr; 22(8):1601-14. PubMed ID: 23314018
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel Drosophila model of nerve injury reveals an essential role of Nmnat in maintaining axonal integrity.
    Fang Y; Soares L; Teng X; Geary M; Bonini NM
    Curr Biol; 2012 Apr; 22(7):590-5. PubMed ID: 22425156
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Maintaining energy homeostasis is an essential component of Wld(S)-mediated axon protection.
    Shen H; Hyrc KL; Goldberg MP
    Neurobiol Dis; 2013 Nov; 59():69-79. PubMed ID: 23892229
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nicotinamide mononucleotide adenylyl transferase-mediated axonal protection requires enzymatic activity but not increased levels of neuronal nicotinamide adenine dinucleotide.
    Sasaki Y; Vohra BP; Lund FE; Milbrandt J
    J Neurosci; 2009 Apr; 29(17):5525-35. PubMed ID: 19403820
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Wld S requires Nmnat1 enzymatic activity and N16-VCP interactions to suppress Wallerian degeneration.
    Avery MA; Sheehan AE; Kerr KS; Wang J; Freeman MR
    J Cell Biol; 2009 Feb; 184(4):501-13. PubMed ID: 19237597
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Wallerian degeneration, wld(s), and nmnat.
    Coleman MP; Freeman MR
    Annu Rev Neurosci; 2010; 33():245-67. PubMed ID: 20345246
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nicotinamide mononucleotide adenylyltransferase expression in mitochondrial matrix delays Wallerian degeneration.
    Yahata N; Yuasa S; Araki T
    J Neurosci; 2009 May; 29(19):6276-84. PubMed ID: 19439605
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting NMNAT1 to axons and synapses transforms its neuroprotective potency in vivo.
    Babetto E; Beirowski B; Janeckova L; Brown R; Gilley J; Thomson D; Ribchester RR; Coleman MP
    J Neurosci; 2010 Oct; 30(40):13291-304. PubMed ID: 20926655
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Highwire ubiquitin ligase promotes axonal degeneration by tuning levels of Nmnat protein.
    Xiong X; Hao Y; Sun K; Li J; Li X; Mishra B; Soppina P; Wu C; Hume RI; Collins CA
    PLoS Biol; 2012; 10(12):e1001440. PubMed ID: 23226106
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A local mechanism mediates NAD-dependent protection of axon degeneration.
    Wang J; Zhai Q; Chen Y; Lin E; Gu W; McBurney MW; He Z
    J Cell Biol; 2005 Aug; 170(3):349-55. PubMed ID: 16043516
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NAD synthase NMNAT acts as a chaperone to protect against neurodegeneration.
    Zhai RG; Zhang F; Hiesinger PR; Cao Y; Haueter CM; Bellen HJ
    Nature; 2008 Apr; 452(7189):887-91. PubMed ID: 18344983
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Axon degeneration: where the Wlds things are.
    Wang JT; Barres BA
    Curr Biol; 2012 Apr; 22(7):R221-3. PubMed ID: 22497934
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reducing expression of NAD+ synthesizing enzyme NMNAT1 does not affect the rate of Wallerian degeneration.
    Conforti L; Janeckova L; Wagner D; Mazzola F; Cialabrini L; Di Stefano M; Orsomando G; Magni G; Bendotti C; Smyth N; Coleman M
    FEBS J; 2011 Aug; 278(15):2666-79. PubMed ID: 21615689
    [TBL] [Abstract][Full Text] [Related]  

  • 15. WldS prevents axon degeneration through increased mitochondrial flux and enhanced mitochondrial Ca2+ buffering.
    Avery MA; Rooney TM; Pandya JD; Wishart TM; Gillingwater TH; Geddes JW; Sullivan PG; Freeman MR
    Curr Biol; 2012 Apr; 22(7):596-600. PubMed ID: 22425157
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of a critical site in Wld(s): essential for Nmnat enzyme activity and axon-protective function.
    Jia H; Yan T; Feng Y; Zeng C; Shi X; Zhai Q
    Neurosci Lett; 2007 Feb; 413(1):46-51. PubMed ID: 17207927
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NAD(+) and axon degeneration revisited: Nmnat1 cannot substitute for Wld(S) to delay Wallerian degeneration.
    Conforti L; Fang G; Beirowski B; Wang MS; Sorci L; Asress S; Adalbert R; Silva A; Bridge K; Huang XP; Magni G; Glass JD; Coleman MP
    Cell Death Differ; 2007 Jan; 14(1):116-27. PubMed ID: 16645633
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Axonal degeneration is blocked by nicotinamide mononucleotide adenylyltransferase (Nmnat) protein transduction into transected axons.
    Sasaki Y; Milbrandt J
    J Biol Chem; 2010 Dec; 285(53):41211-5. PubMed ID: 21071441
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The cellular distribution of the Wld s chimeric protein and its constituent proteins in the CNS.
    Fang C; Bernardes-Silva M; Coleman MP; Perry VH
    Neuroscience; 2005; 135(4):1107-18. PubMed ID: 16154290
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Degeneration of Injured Axons and Dendrites Requires Restraint of a Protective JNK Signaling Pathway by the Transmembrane Protein Raw.
    Hao Y; Waller TJ; Nye DM; Li J; Zhang Y; Hume RI; Rolls MM; Collins CA
    J Neurosci; 2019 Oct; 39(43):8457-8470. PubMed ID: 31492772
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.